Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: BMS, Catalyst, Chiasma, CNS, Cullinan, Gilead, Hansa, Medexus, Mediwound, Merck, Moderna, Neurogene, Orchard, Palatin, Prilenia, Rafael, Tracon, Vico, Yiling.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Alterity, Amgen, Astellas, Astrazeneca, Beigene, Biogen, Bioheng, Eisai, Fibrogen, Hutchison China Meditech, Hutchmed, Huyabio, I-Mab, Innocare, Kite, Lynk, Medicenna, Medolife Rx, Merck, Merz, Poxel, Prestige, PTC, RDIF, Resolve, Samsung Bioepis, Sanotize Research and Development, Santen, Senhwa, Shanghai Fosun, Shenzhen Chipscreen, Sumitomo Dainippon, Teijin, Teva.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abiomed, Attana, Front Line Medical, Galderma, Neuros Medical.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Agios, Asklepios, Astrazeneca, Atsena, Biomarin, Biontech, Braeburn, Camurus, Catalyst, Cend, Chugai, Genentech, Immunicum, Innocare, Innovent, Junshi, Kymera, Moderna, Oric, Pfizer, Regeneron, Roche, Rockwell, Saniona, Sanofi, Syndax, Zentalis.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Angelmed.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, Adial, Astellas, Aurinia, Biomarin, BMS, I-Mab, Incyte, Innocare, Jazz, Lynk, Mirati, Morphosys, Nicox, RDIF, Regeneron, Samsung, Y-Mabs.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Axonics, Peijia Medical.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alnylam, Aquestive, Astrazeneca, Biogen Eli Lilly, Eisai, Huyabio, In3bio, Merck, Pieris, Roche, Santen, Vectivbio.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Diabetomics, Oticon Medical, Otolith Labs, Sorrento Therapeutics.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alterity, Amgen, Astrazeneca, Beigene, Bionaut, Biovie, Eisai, Genprex, Huyabio, Incarda, Halozyme, Janssen, Kite, Medicenna, Medolife, Merz, Nanoscope, Poxel, PTC, Resolve, Revolo, Sanotize, Senhwa Biosciences, Teva, Y-Mabs.